Angina pharmacology - Ipswich-Year2-Med-PBL-Gp-2

advertisement

Angina pharmacology

Summary

Drugs

– Stable angina management: reduce heart O

2

Nitrates (reduce venous return)

Beta blockers (reduce sympathetic drive)

Calcium channel blockers (reduce inotropic state) demand

– Refractory stable angina options

• Perhexiline, Ivabradine

– Preventative agents

• Thrombosis prophylaxis

( Aspirin , clopidigrel, dipyrimadole, heparins)

• Statins

• ACE inhibitors

• Diuretics

Triple Whammy

ACE Inhibitor, diuretic, and NSAID: a dangerous combination

(TGA.gov.au, Australian Adverse Drug Reactions Bulletin 2003)

• NSAID + Diuretic + ACE inhibitor

• Correlation with Renal failure

• ADRAC wishes to remind prescribers that the combination of ACE inhibitors (or angiotensin receptor antagonists), diuretics and

NSAIDs (including COX-2 inhibitors) should be avoided if possible, and great care should be taken with ACE inhibitors and NSAIDs in patients with renal impairment.

Nitrates

Mechanism

– Release nitric oxide (NO)

– NO dilates venules and coronary arteries

– Increases venous capacitance

– Decreases preload

– Decreases contractility (Frank-Starling mechanism)

Nitrates

• Adverse effects

– Headaches, hypotension, flushing, palpitations, orthostatic hypotension, fainting, peripheral oedema, contact dermatitis

• Contraindications

– Hypovolemia or hypotension

– Raised intracranial pressure

– Significant anemia

– G6PD deficiency (risk of hemolytic anemia)

– Recent (1-5 days) use of PDE5 inhibitors (excacerbates hypotension)

– hypertrophic obstructive cardiomyopathy

– cardiac tamponade

– Aortic stenosis, mitral stenosis, cor pulmonale.

• Precautions

Tolerance. 10-12 hour nitrate free interval recommended each day.

Withdrawal. Reduce dose gradually.

Nitrates

Drug Fast GTN Slow GTN Isosorbide dinitrate

Isosorbide mononitrate

Route Sublingual Transdermal Oral/sublingual Oral

500 mcg prn 10mg daily 10mg q.i.d

60mg daily Example

Dose

Trade name

Nitrolingual,

Lycinate,

Anginine

Minitran,

Nitro-dur

Sorbidin, Isordil Imtrate, Duride,

Imdur, Monodur

Nicorandil

Oral

10mg b.i.d

Ikorel

Nicorandil

Also opens KATP channels in smooth muscle, dilating arterial as well as venous vessels.

Can cause ulcers, often in the mouth.

Nitrates

GIT availability

Route

Glyceryl trinitrate

Onset poor sublingual (tablet, spray) <5 minutes patch

IV infusion

Isosorbide dinitrate

30–60 minutes

<10 minutes oral tablet

20–25% sublingual tablet

Isosorbide mononitrate

15–40 minutes

<10 minutes

100% controlled release tablet 1–2 hours

Australian Medicines Handbook

Duration

<1 hour prolonged

4–6 hours

1–2 hours prolonged

β-blockers

Competitively antagonise beta adrenergic receptors

Blunt sympathetic stimulation

Reduce contractility and rate

No reflex rise in peripheral resistance

β-1 receptors mainly in heart muscle

β-2 receptors mainly in lungs and peripheral vessels

β-3 receptors mainly in heart and adipose tissue

β-blockers

• Contraindications

– Reversible airway disease

– Cardiogenic and hypovolemic shock

– Prinzmetal (vasospasm) angina

– Bradycardia, 2 nd and 3 rd degree Heart block, Sick sinus

• Adverse effects

– nausea, diarrhoea, bronchospasm, dyspnoea, cold extremities, exacerbation of

Raynaud's syndrome, bradycardia, hypotension, orthostatic hypotension (carvedilol, labetalol), heart failure, heart block, fatigue, dizziness, abnormal vision, decreased concentration, hallucinations, insomnia, nightmares, depression, alteration of glucose and lipid metabolism, oedema (carvedilol)

• Precautions

Diabetes: hypoglycemia sign can be masked

Hyperthyroidism: signs masked

Anaphylaxis risk: Reduces epipen effect

Phaeochromocytoma: aggravates hypertension

Myasthenic symptoms: aggravated

Peripheral vascular disease or Raynaud’s phenomenon: aggravated

– Renal or hepatic impairment: Choose drug with appropriate elimination route

β-blockers for angina

Drug

Metoprolol

Propanolol

Atenolol

Oxyprenolol

Pindalol

Receptors beta

1

Elimination Daily doses hepatic 1–2

Trade name hepatic 2–3

Betaloc, Lopressor,

Metohexal, Minax,

Metrol

Deralin, Inderal beta

1

, beta

2 beta

1 renal beta

1

, beta

2

, symp Hepatic beta

1

, beta

2

, symp Renal

1

2-3

2-3

Noten, Tensig, Tenormin

Corbiton

Barbloc, Visken

Australian Medicines Handbook

L-type Calcium channel blockers

Dihydropyridines

– Strong vasodilation (arterial)

– Decreases afterload

Phenylalkylamine

– Verapamil

– (less) Vasodilation and (more) cardiac depression

– Decreases afterload, heart rate, and contractility

Benzothiazepine

– Diltiazem

– (more) Vasodilation and (less) cardiac depression

– Decreases afterload, heart rate, and contractility

L-type Calcium channel blockers

• Contraindications

– Cardiogenic shock, Heart failure, Aortic stenosis

• Adverse effects

– Transient worsening of angina symptoms

– Reflex tachycardia (short acting dihydropyridines)

Bradycardia (Diltiazem, Verapamil)

– Headache, flushing, peripheral oedema (especially dihydropyridines)

– Gingival hyperplasia

– Constipation (Verapamil)

– Rash, fatigue, dizziness, nausea, abdominal pain

• Precautions

Myasthenia-like disease – exacerbated symptoms

Avoid β blockers with Verapamil

Use β blocker with dihydropyridines? (Murtagh)

– CCB related oedema may not respond to diuretics

L-type Calcium channel blockers

Duration Drug

Verapamil

Diltiazem

Amlodipine

Felodipine

Nifedipine

Lercandipine

Long

Short

Short

Long

Example dose Trade name

80mg bid

30mg tid

180mg daily LA

5mg daily

Anpec, Isoptin, Cordilox,

Veracps

Cardizem, Coras, Dilzem,

Vasocardol, Diltahexal

Amlo, Nordip, Norvapine,

Norvasc

5mg daily (LA) Felodur, Felodil, Plendil

20mg bid Adalat, Adefin, Nifexal

10mg daily Zanidip

Australian Medicines Handbook

Nimodipine is a CCB indicated for subarachnoid hemorrhage management

Refractory stable angina options

Perhexiline

Australian Medicines Handbook

Mechanism

Adverse effects

Unclear. Calcium channel blocker?

Carnitine palmitoyltransferase 1 inhibitor?

Peripheral neuropathy

Hepatotoxicity

Precautions

CYP2D6 saturable metabolism.

- Identify slow metabolizers

- Monitor plasma levels

- Titrate dose when changing other drugs

Trade name Pexsig

Saturable hepatic metabolism

• Australian Medicines Handbook – Drugs and CYP enzymes

• Cytochrome P450 enzyme family

– CYP1A2

– CYP2B6

– CYP2C8

– CYP2C9

– CYP2C19

– CYP2D6

– CYP3A4/5

• Interactions

– Grapefruit, Starfruit , St John’s Wort, Nicotine, Watercress

– Pharmaceuticals

Refractory stable angina options

Ivabradine

Australian Public Assessment Report for Ivabradine

Australian Medicines Handbook

Mechanism

Inhibits I f

(not so funny now)

Lowers heart rate

Side effects

Prolongs QT interval

“Luminous phenomena” (Retinal I h current)

Trade name Coralan

PBS Not subsidised

Download